7616-22-0
7616-22-0
Chemical Structure
(±)-γ-Tocopherol
- CAS No.: 7616-22-0
- Formula:C28H48O2
- Molecular Weight:416.68
IUPAC Name: 2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol
InChIKey: QUEDXNHFTDJVIY-UHFFFAOYSA-N
SMILES: OC1=C(C)C(C)=C2C(CCC(CCCC(C)CCCC(C)CCCC(C)C)(C)O2)=C1
Biological Activity: (±)-γ-Tocopherol is an endogenous metabolite present in Blood that can be used for the research of Prostate Cancer and Endometrial Cancer[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(±)-γ-Tocopherol | 99.44% | (±)-γ-Tocopherol is an endogenous metabolite present in Blood that can be used for the research of Prostate Cancer and Endometrial Cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]
- [2]. Key TJ, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2007 Sep;86(3):672-81. [Content Brief]
- [3]. Jeong NH, et al. Preoperative levels of plasma micronutrients are related to endometrial cancer risk. Acta Obstet Gynecol Scand. 2009;88(4):434-9. [Content Brief]
Keywords
